The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has released a funding opportunity titled the Cancer Prevention and Control Clinical Trials Planning Grant Program (R34). This program aims to support the planning of clinical trials that focus on improving cancer prevention, detection, and survivorship. It specifically addresses gaps in preliminary data, participant recruitment strategies, and study designs needed to finalize trial protocols. Eligible organizations, including higher education institutions and nonprofits, can apply for up to $225,000 per year for a maximum period of three years, with an emphasis on enhancing diverse perspectives in the research teams. Key dates include an open submission date of January 25, 2025, with subsequent review cycles. Applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application, which will be assessed during peer review. The document outlines specific eligibility requirements, application instructions, and funding restrictions, stressing the need for compliance with NIH policies throughout the application process. Overall, this initiative aims to facilitate rigorous planning processes that lead to effective cancer intervention trials that align with public health goals.